Abstract:Background McH-lpr/lpr-RA1 mice are a new strain of mice which spontaneously develop destructive arthritis and enthesitis in the ankle. There is no published data that drug treatment has been trialed on these mice. This study examined the effect of the mouse anti-IL-6 receptor antibody, MR16–1, for the treatment of arthritis and enthesitis in McH-lpr/lpr-RA1 mice. Methods Male McH-lpr/lpr-RA1 mice were randomly divided into control and treatment groups. MR16–1 was administered from 10 weeks of age for the treatment group. Saline was applied for the control group. The drug was administered once a week, at an initial dose of 2 mg, then maintained at 0.5 mg once per week thereafter. The effects were evaluated by the histopathological synovitis score, in vivo imaging using indocyanine green liposomes, and analysis of the gene expression of inflammatory cytokines. Results Tissue analyses were carried out at 14, 17 and 20 weeks of age. The synovitis scores of treated groups were significantly lower compared with those of the control group at 14 and 17 weeks of age. The kappa coefficient was 0.77. However, progression of entheseal ossification persisted in the MR16–1 treated group. In vivo imaging using indocyanine green liposomes showed significant decreases in signal intensities of treated groups at week 14, but no significant differences were observed at week 18. Blood serum amyloid A levels in treated groups were significantly lower at 17 weeks of age. The gene expression levels of Tnf and Il17 were also significantly lower in MR16–1 treated groups. Conclusions Administration of the anti-IL-6 receptor antibody is effective for the treatment of synovitis and bone destruction of McH-lpr/lpr-RA1 mice. McH-lpr/lpr-RA1 mice may be a suitable experimental model for the development of new treatments for destructive arthritis and enthesitis. IL-6 signal blockade could contribute to the treatment of destructive arthritis, and further studies should be carried out to confirm its potential in the prevention of enthesopathy developed to ossification.

Short-Term Administration of Selected Anti-T-Cell Receptor V-Beta Chain Specific Moab Reduces Sialadenitis in Mrl/Lpr Mice

Effects on Sialadenitis after Cellular Transfer in Autoimmune MRL/lprMice

Sialadenitis in the MRL-l mouse: morphological and immunohistochemical characterization of resident and infiltrating cells.

Oligoclonality of T Cells in Salivary Glands of Autoimmune MRL/lpr Mice.

Effect of Anti-Tnf-α Antibody on Mucosal Lymphocyte Apoptosis in Chronic Colitis Mice

Blockade of CD28/CTLA-4-B7 Costimulatory Pathway in Colitic SCID Mice

Co-Expression of Il-18 Binding Protein and Il-4 Regulates Th1/Th2 Cytokine Response in Murine Collagen-Induced Arthritis

Effects on Experimental Allergic Neuritis in Rats by in Vivo Treatment with Monoclonal Anti-T-cell Antibodies

Invivo Treatment with W3/13 (Anti-Pan-t) but Not with Ox8 (Anti-Suppressor Cytotoxic-T) Monoclonal-Antibodies Impedes the Development of Adjuvant Arthritis in Rats

In Vivo Generation of SSA/Ro Antigen–Specific Regulatory T Cells Improves Experimental Sjögren's Syndrome in Mice

Anti-T-Cell Receptor Antibody Treatment of Rats with Established Autologous Collagen-Induced Arthritis - Suppression of Arthritis Without Reduction of Anti-Type-Ii Collagen Autoantibody Levels

Efficacy of BAFF inhibition and B-cell depletion in non-obese diabetic mice as a spontaneous model for Sjögrens disease

Reconstruction of Sjögren's syndrome-like sialadenitis by a defined disease specific gut-reactive single TCR and an autoantibody

Podoplanin expressing macrophages and their involvement in tertiary lymphoid structures in mouse models of Sjögren's disease

The effect of anti-IL-6 receptor antibody for the treatment of McH-lpr/lpr-RA1 mice that spontaneously developed destructive arthritis and enthesitis

Therapeutic Effects of Monoclonal Antibodies to Αβtcr but Not to CD4 on Collagen-Induced Arthritis in the Rat

Treatment with a CD40 Antagonist Antibody Reverses Severe Proteinuria and Loss of Saliva Production and Restores Glomerular Morphology in Murine Systemic Lupus Erythematosus

AB0136 The effect of il-6 receptor antibody for the treatment of mch-lpr/lpr-ra1 mice that spontaneously developed ankylosing arthritis

Inhibition of Cathepsin S in Autoimmune CD25KO Mouse Improves Sjögren Disease-Like Lacrimal Gland Pathology

In Vivo Treatment with Anti‐cd8 and Anti‐cd5 Monoclonal Antibodies Alters Induced Tolerance to Adjuvant Arthritis

Sialoadenitis Progression in Nonobese Diabetic Mice and Its Correlation with Expression of Apoptosis-Associated Proteins in Salivary Glands and Serum IgG Levels.